Natural product extracts that reduce accumulation of the alzheimer’s amyloid β peptide


Alzheimer’s disease (AD) is the most common form of dementia in the elderly. Without a treatment that significantly delays the progression of the disease over 14 million Americans are likely to be affected with AD by the middle of the 21st Century, presenting an enormous economic and social burden. Evidence gathered over the last two decades has implicated… (More)
DOI: 10.1007/s12031-002-0023-5


4 Figures and Tables